Literature DB >> 8440952

Long-term follow-up of patients with bacterial vaginosis treated with oral metronidazole and topical clindamycin.

J D Sobel, C Schmitt, C Meriwether.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8440952     DOI: 10.1093/infdis/167.3.783

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  28 in total

Review 1.  Vaginal bacterial phaginosis?

Authors:  A L Blackwell
Journal:  Sex Transm Infect       Date:  1999-10       Impact factor: 3.519

2.  Findings associated with recurrence of bacterial vaginosis among adolescents attending sexually transmitted diseases clinics.

Authors:  Rebecca M Brotman; Emily J Erbelding; Roxanne M Jamshidi; Mark A Klebanoff; Jonathan M Zenilman; Khalil G Ghanem
Journal:  J Pediatr Adolesc Gynecol       Date:  2007-08       Impact factor: 1.814

3.  A pilot clinical trial comparing an acid-buffering formulation (ACIDFORM gel) with metronidazole gel for the treatment of symptomatic bacterial vaginosis.

Authors:  Jose A Simoes; Luis G Bahamondes; Rodrigo P S Camargo; Valeria M N Alves; Lourens J D Zaneveld; Donald P Waller; Jill Schwartz; Marianne M Callahan; Christine K Mauck
Journal:  Br J Clin Pharmacol       Date:  2006-02       Impact factor: 4.335

4.  Polyethylene glycol-based hydrogels for controlled release of the antimicrobial subtilosin for prophylaxis of bacterial vaginosis.

Authors:  Sujata Sundara Rajan; Veronica L Cavera; Xiaoping Zhang; Yashveer Singh; Michael L Chikindas; Patrick J Sinko
Journal:  Antimicrob Agents Chemother       Date:  2014-02-24       Impact factor: 5.191

Review 5.  Vaginal microbiota and susceptibility to HIV.

Authors:  McKenna C Eastment; R Scott McClelland
Journal:  AIDS       Date:  2018-03-27       Impact factor: 4.177

Review 6.  Vaginal microbiome: rethinking health and disease.

Authors:  Bing Ma; Larry J Forney; Jacques Ravel
Journal:  Annu Rev Microbiol       Date:  2012-06-28       Impact factor: 15.500

7.  Microbiologic response to treatment of bacterial vaginosis with topical clindamycin or metronidazole.

Authors:  M N Austin; R H Beigi; L A Meyn; S L Hillier
Journal:  J Clin Microbiol       Date:  2005-09       Impact factor: 5.948

8.  The restoration of the vaginal microbiota after treatment for bacterial vaginosis with metronidazole or probiotics.

Authors:  Zongxin Ling; Xia Liu; Weiguang Chen; Yueqiu Luo; Li Yuan; Yaxian Xia; Karen E Nelson; Shaolei Huang; Shaoen Zhang; Yuezhu Wang; Jieli Yuan; Lanjuan Li; Charlie Xiang
Journal:  Microb Ecol       Date:  2012-12-19       Impact factor: 4.552

Review 9.  Current Treatment of Bacterial Vaginosis-Limitations and Need for Innovation.

Authors:  Catriona S Bradshaw; Jack D Sobel
Journal:  J Infect Dis       Date:  2016-08-15       Impact factor: 5.226

Review 10.  Metronidazole. A therapeutic review and update.

Authors:  C D Freeman; N E Klutman; K C Lamp
Journal:  Drugs       Date:  1997-11       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.